Literature DB >> 29941353

Advances in the development of molecular genetic tools for Mycobacterium tuberculosis.

Chiranjibi Chhotaray1, Yaoju Tan2, Julius Mugweru3, Md Mahmudul Islam1, H M Adnan Hameed1, Shuai Wang1, Zhili Lu4, Changwei Wang4, Xinjie Li2, Shouyong Tan2, Jianxiong Liu5, Tianyu Zhang6.   

Abstract

Mycobacterium tuberculosis, a clinically relevant Gram-positive bacterium of great clinical relevance, is a lethal pathogen owing to its complex physiological characteristics and development of drug resistance. Several molecular genetic tools have been developed in the past few decades to study this microorganism. These tools have been instrumental in understanding how M. tuberculosis became a successful pathogen. Advanced molecular genetic tools have played a significant role in exploring the complex pathways involved in M. tuberculosis pathogenesis. Here, we review various molecular genetic tools used in the study of M. tuberculosis. Further, we discuss the applications of clustered regularly interspaced short palindromic repeat interference (CRISPRi), a novel technology recently applied in M. tuberculosis research to study target gene functions. Finally, prospective outcomes of the applications of molecular techniques in the field of M. tuberculosis genetic research are also discussed.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Drug resistance; Ggram-positive; Molecular genetic tools; Mycobacterium tuberculosis; Recombineering

Year:  2018        PMID: 29941353     DOI: 10.1016/j.jgg.2018.06.003

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  8 in total

1.  Multiplex Real-Time PCR-shortTUB Assay for Detection of the Mycobacterium tuberculosis Complex in Smear-Negative Clinical Samples with Low Mycobacterial Loads.

Authors:  Fernando Alcaide; Rocío Trastoy; Raquel Moure; Mónica González-Bardanca; Antón Ambroa; María López; Inés Bleriot; Lucia Blasco; Laura Fernandez-García; Marta Tato; German Bou; María Tomás
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

2.  Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9.

Authors:  Aniek S Meijers; Ran Troost; Roy Ummels; Janneke Maaskant; Alexander Speer; Sergey Nejentsev; Wilbert Bitter; Coenraad P Kuijl
Journal:  Tuberculosis (Edinb)       Date:  2020-08-12       Impact factor: 2.973

3.  Improving the stability of the TetR/Pip-OFF mycobacterial repressible promoter system.

Authors:  Francesca Boldrin; Saber Anoosheh; Agnese Serafini; Laura Cioetto Mazzabò; Giorgio Palù; Roberta Provvedi; Riccardo Manganelli
Journal:  Sci Rep       Date:  2019-04-08       Impact factor: 4.379

4.  A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis.

Authors:  Mei-Yi Yan; Si-Shang Li; Xin-Yuan Ding; Xiao-Peng Guo; Qi Jin; Yi-Cheng Sun
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.867

Review 5.  Handling the Hurdles on the Way to Anti-tuberculosis Drug Development.

Authors:  Pedro F Dalberto; Eduardo V de Souza; Bruno L Abbadi; Christiano E Neves; Raoní S Rambo; Alessandro S Ramos; Fernanda S Macchi; Pablo Machado; Cristiano V Bizarro; Luiz A Basso
Journal:  Front Chem       Date:  2020-11-19       Impact factor: 5.221

6.  Low-cost anti-mycobacterial drug discovery using engineered E. coli.

Authors:  Nadine Bongaerts; Zainab Edoo; Ayan A Abukar; Xiaohu Song; Sebastián Sosa-Carrillo; Sarah Haggenmueller; Juline Savigny; Sophie Gontier; Ariel B Lindner; Edwin H Wintermute
Journal:  Nat Commun       Date:  2022-07-07       Impact factor: 17.694

7.  Comparative Analysis of Whole-Genome and Methylome Profiles of a Smooth and a Rough Mycobacterium abscessus Clinical Strain.

Authors:  Chiranjibi Chhotaray; Shuai Wang; Yaoju Tan; Amjad Ali; Muhammad Shehroz; Cuiting Fang; Yang Liu; Zhili Lu; Xingshan Cai; H M Adnan Hameed; Md Mahmudul Islam; Goverdhan Surineni; Shouyong Tan; Jianxiong Liu; Tianyu Zhang
Journal:  G3 (Bethesda)       Date:  2020-01-07       Impact factor: 3.154

8.  Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase.

Authors:  Xin-Yuan Ding; Si-Shang Li; Yi-Man Geng; Mei-Yi Yan; Guo-Bao Li; Guo-Liang Zhang; Yi-Cheng Sun
Journal:  Front Genome Ed       Date:  2021-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.